Literature DB >> 25399732

A quest--halting the progression of autosomal dominant polycystic kidney disease.

David H Ellison1, Julie R Ingelfinger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25399732     DOI: 10.1056/NEJMe1412586

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 2.  Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function.

Authors:  Raquel Esteras; Maria Vanessa Perez-Gomez; Laura Rodriguez-Osorio; Alberto Ortiz; Beatriz Fernandez-Fernandez
Journal:  Ther Adv Drug Saf       Date:  2015-08

3.  Fluoroscopy versus ultrasonography guided mini-percutaneous nephrolithotomy in patients with autosomal dominant polycystic kidney disease.

Authors:  Heyang Sun; Ze Zhang; Guanghao Huang; Shaw P Wan; Huade Chen; Bolin He; Jian Yuan; Yongda Liu
Journal:  Urolithiasis       Date:  2016-07-04       Impact factor: 3.436

4.  Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.

Authors:  María V Irazabal; Kaleab Z Abebe; Kyongtae Ty Bae; Ronald D Perrone; Arlene B Chapman; Robert W Schrier; Alan S Yu; William E Braun; Theodore I Steinman; Peter C Harris; Michael F Flessner; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2017-11-01       Impact factor: 5.992

5.  Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care.

Authors:  Luca De Nicola; Michele Provenzano; Paolo Chiodini; Silvio Borrelli; Carlo Garofalo; Mario Pacilio; Maria Elena Liberti; Adelia Sagliocca; Giuseppe Conte; Roberto Minutolo
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 6.  Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD.

Authors:  Roberto Pagliarini; Christine Podrini
Journal:  Front Med (Lausanne)       Date:  2021-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.